Kidney disease patients treated at for-profit dialysis centers are 20 percent less likely to be informed about transplant options and referred for the potentially lifesaving operation than those at nonprofit centers, new Johns Hopkins research suggests.
Changing the organ donation process in this country from opt-in — by, say, checking a box on a driver’s license application— to opt-out, which presumes someone’s willingness to donate after death unless they explicitly object while alive, would not be likely to increase the donation rate in the United States, new Johns Hopkins research suggests.
White heart transplant patients under the age of 18 are more than twice as likely to be alive a decade after surgery as their African-American counterparts, new Johns Hopkins research suggests.
Kidney transplants performed using organs from live donors over the age of 70 are safe for the donors and lifesaving for the recipients, new Johns Hopkins research suggests. The study shines new light on a long-ignored potential source of additional organs that could address a profound national shortage.
Johns Hopkins researchers have developed a way to stimulate a rat’s stem cells after a liver transplant as a means of preventing rejection of the new organ without the need for lifelong immunosuppressant drugs. The need for anti-rejection medicines, which carry serious side effects, is a major obstacle to successful long-term transplant survival in people
For years, medical studies have reached the same conclusion: African-American patients do better on kidney dialysis than their white counterparts. But new Johns Hopkins research, published in the Journal of the American Medical Association, shows that younger blacks — those under the age of 50 — actually do much worse on dialysis than equally sick whites who undergo the same blood-filtering process.
A national transplant policy change designed to give African-American patients greater access to donor kidneys has sliced in half the racial disparities that have long characterized the allocation of lifesaving organs, new Johns Hopkins research suggests.
Hard-to-match kidney transplant candidates who receive a treatment designed to make their bodies more accepting of incompatible organs are twice as likely to survive eight years after transplant surgery as those who stay on dialysis for years awaiting compatible organs, new Johns Hopkins research finds.
Despite concerns that surgeon fatigue is leading to dangerous complications for patients and data showing worse outcomes for many patients who undergo surgery at night, new Johns Hopkins research suggests that — in the case of heart and lung transplants — time of day has no affect on patient survival.
Johns Hopkins researchers have demonstrated that human liver cells derived from adult cells coaxed into an embryonic state can engraft and begin regenerating liver tissue in mice with chronic liver damage.
Older, sicker heart-transplant recipients are significantly more likely to be alive a year after their operations if they have their transplants at hospitals that do a large number of them annually, new Johns Hopkins research suggests. These patients fare less well at low-volume centers, the research shows.